NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nirrin Technologies

Nirrin Technologies

Private
Billerica, MassachusettsHealthcare & Life Scienceshttps://www.nirrin.tech/

Last Round

Seed Round

Jun 15, 2026

Total Funding Raised

$6.82M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Nirrin Technologies is a biotechnology company that develops analytical instruments with proprietary laser spectroscopy technology for real-time bioprocess monitoring and protein quantitation.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Sensors, Smart Manufacturing, Quality Management

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

process analytical technologyPATbioprocess monitoringspectroscopy systemsnear-infrared spectroscopybioprocess analyticsanalytical instrumentsprotein quantitationin-line monitoringreal-time measurementbiologics manufacturingtunable laser spectroscopycell and gene therapyHPTLS21 CFR Part 11

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nirrin Technologies Comparables

Compare Nirrin Technologies with similar companies based on industry and business-model similarity.

Nirrin Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IRUBIS
88%
Endress+Hauser
76%
Bruker
75%

Nirrin Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 15, 2026
GrantSep 4, 2024
Series AFeb 1, 2024
VC RoundSep 23, 2021

Nirrin Technologies Investors

Notable investors and investment history

Nirrin Technologies investors
InvestorRounds
Gamma BiosciencesVC Round
NIH RADxGrant
Anzu PartnersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased from 0 to 7, representing 35% of headcount.

  • Jun 15, 2026

    Raised $7M in a Seed Round.

Nirrin Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nirrin Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nirrin Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersBillerica, Massachusetts
Employee Range20
Year Founded2018
Last FundingJun 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.